In his 10-year tenure over the program, Mr. Miller said that a case involving Ms. Mattek-Sands — the American tennis player whose files were published on Wednesday — was the only one WADA had overturned.
Her application for drugs to treat “adrenal insufficiency” — hydrocortisone and DHEA — was approved in 2013 by the tennis federation but revoked in 2014 by WADA, which believed DHEA would enhance her performance.
Stuart Miller, director of the International Tennis Federation’s antidoping program, approved Ms. Mattek-Sands’s applications for exemptions. He said that of the hundreds of applications he had approved in his 10-year tenure at the federation, hers were the only ones overruled by WADA.
Dr. Rogol said DHEA, a precursor of testosterone, should never be approved for use by a female athlete.
“It’s going to be turned, likely, into relatively small doses of testosterone, which of course for a woman, even small doses are performance enhancing,” Dr. Rogol said. “Women’s testosterone levels are normally perhaps a tenth of men’s, so if you boost them up to a fifth or a fourth of men’s, there likely will be an advantage.”
Dr. Rogol called the Court of Arbitration’s expert “spot on” in his reasons for ultimately ruling against Ms. Mattek-Sands.
“
I think it tells you that tennis is a little bit more insular,” he said of the federation’s initial approval.
Read
full article at NY times .
Also, BMS's doctor is one Dr. Serrano who has openly admitted to working with thousands of steroids using atheletes. :cover
The court’s decision against Ms. Mattek-Sands included footnotes expressing its surprise at what it called an The boy crazier than I thought. Stuart miller approves exemption in 2013 for BMS for DHEA (testosterone), it gets overturned by WADA in July 2014 and Stuart Miller approves it again in August 2014 and that too for the same player :lolz: Again WADA overturned it.
